Martin G. Larson

发表

Structural Equation Modeling for Analyzing Erythrocyte Fatty Acids in Framingham

Jun Ye, Gemechis D. Djira, Mark A. Espeland, 2014, Comput. Math. Methods Medicine.

Quantitative Comparison of Statistical Methods for Analyzing Human Metabolomics Data

Olga V. Demler, Mir Henglin, Susan Cheng, 2017, Metabolites.

Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study

Michael J. Pencina, Ralph B. D’Agostino, Martin G. Larson, 2009, Circulation.

Atrial Fibrillation Begets Heart Failure and Vice VersaCLINICAL PERSPECTIVE

David D. McManus, Susan Cheng, Na Wang, 2016 .

A mixture model for the regression analysis of competing risks data

Gregg E. Dinse, Martin G. Larson, M. Larson, 1985 .

Incidence and prognosis of syncope

Ming-Hui Chen, Daniel Levy, Martin G. Larson, 2003 .

Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes

Ming-Huei Chen, Susan Cheng, Clary B. Clish, 2016, PloS one.

Multiple imputation and analysis for high‐dimensional incomplete proteomics data

Daniel Levy, Aram Adourian, Martin G. Larson, 2015, Statistics in medicine.

A note on semi-Markov models for partially censored data

Gregg E. Dinse, Martin G. Larson, M. Larson, 1986 .

A Global View of the Relationships between the Main Behavioural and Clinical Cardiovascular Risk Factors in the GAZEL Prospective Cohort

Pierre Meneton, Marcel Goldberg, Joël Ménard, 2016, PloS one.

Electrocardiographic QRS Duration and the Risk of Congestive Heart Failure: The Framingham Heart Study

Michael J. Pencina, Byung-Ho Nam, Ralph B. D'Agostino, 2006, Hypertension.

Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction: Insights From the Framingham Heart Study of the National Heart, Lung, and Blood Institute

Daniel Levy, Martin G. Larson, Jack V. Tu, 2009, Circulation.

Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease

Xu Shi, Hasmik Keshishian, Steven A. Carr, 2016, Circulation.

Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE Consortium

Ming-Huei Chen, Qiong Yang, Nicole Soranzo, 2010 .

Circulating CD31+ leukocyte frequency is associated with cardiovascular risk factors.

Susan Cheng, Stanley Y. Shaw, Martin G. Larson, 2013, Atherosclerosis.

Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging?: The Framingham Heart Study

Martin G. Larson, Nathan D. Wong, Daniel Levy, 2001, Circulation.

Long-Term Epidemiologic Prediction of Coronary Disease

Martin G. Larson, W. Kannel, M. Larson, 1993 .

Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block.

Daniel Levy, Martin G. Larson, Emelia J. Benjamin, 2009, JAMA.

Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study

Michael J. Pencina, Daniel Levy, Martin G. Larson, 2010, Circulation.

Reduced Heart Rate Variability and Mortalit Risk in an Elderly Cohort: The Framingham Heart Study

Ferdinand J. Venditti, Martin G. Larson, Charles L. Feldman, 1994, Circulation.

Methylome-wide Association Study of Atrial Fibrillation in Framingham Heart Study

Zhijun Xie, David D. McManus, Honghuang Lin, 2017, Scientific Reports.

Genome-wide association study of PR interval

Christian Gieger, Thomas Meitinger, Jan A. Kors, 2010, Nature Genetics.

Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium

David D. McManus, Vilmundur Gudnason, Michael J. Pencina, 2013, Journal of the American Heart Association.

Long‐term Cardiovascular Risks Associated With an Elevated Heart Rate: The Framingham Heart Study

Susan Cheng, Martin G. Larson, R. Vasan, 2014, Journal of the American Heart Association.

Relations of Arterial Stiffness and Brachial Flow–Mediated Dilation With New-Onset Atrial Fibrillation: The Framingham Heart Study

David D. McManus, Na Wang, Jared W. Magnani, 2016, Hypertension.

Protein Biomarkers of Cardiovascular Disease and Mortality in the Community

Daniel Levy, Martin G. Larson, D. Levy, 2018, Journal of the American Heart Association.

Visualization, Quantification, and Alignment of Spectral Drift in Population Scale Untargeted Metabolomics Data.

Mir Henglin, Susan Cheng, Jeramie D. Watrous, 2017, Analytical chemistry.

Relations of Plasma Matrix Metalloproteinase-9 to Clinical Cardiovascular Risk Factors and Echocardiographic Left Ventricular Measures: The Framingham Heart Study

Johan Sundström, Daniel Levy, Martin G. Larson, 2004, Circulation.

Aortic stiffness, blood pressure progression, and incident hypertension.

Daniel Levy, Jian Rong, Martin G. Larson, 2012, JAMA.

Evidence for a Gene Influencing Blood Pressure on Chromosome 17: Genome Scan Linkage Results for Longitudinal Blood Pressure Phenotypes in Subjects From the Framingham Heart Study

Anita L. DeStefano, Richard H. Myers, L. Adrienne Cupples, 2000, Hypertension.

Genome-wide Association Study Of Plasma Proteins Identifies Putatively Causal Genes, Proteins, And Pathways For Cardiovascular Disease

Christian Gieger, Karsten Suhre, Andrew D. Johnson, 2017, bioRxiv.

Descriptive Statistics and Graphical Displays

Martin G. Larson, M. Larson, 2006, Circulation.

Consent for genetic research in the Framingham Heart Study

Ralph B. D’Agostino, L. Adrienne Cupples, Caroline S. Fox, 2010, American journal of medical genetics. Part A.

Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry

Eric Boerwinkle, Vilmundur Gudnason, Thomas Lumley, 2009, Nature Genetics.